Dementia Drugs Market Size, Top Share, Demand, Forecast to 2033

Market Segmentation

Dementia Drugs Market, By Indications (2021–2033)

Lewy Body Dementia
Parkinsons Disease Dementia
Alzheimers Disease
Vascular Dementia
Other Indications

Dementia Drugs Market, By Drug Class (2021–2033)

MAO-B Inhibitors
Glutamate Inhibitors
Cholinesterase Inhibitors

Regional Dementia Drugs Market

North America
1. North America Dementia Drugs Market, By Indications
  1. Lewy Body Dementia
  2. Parkinsons Disease Dementia
  3. Alzheimers Disease
  4. Vascular Dementia
  5. Other Indications
2. North America Dementia Drugs Market, By Drug Class
  1. MAO-B Inhibitors
  2. Glutamate Inhibitors
  3. Cholinesterase Inhibitors
3. U.S.
  1. U.S. Dementia Drugs Market, By Indications
    1. Lewy Body Dementia
    2. Parkinsons Disease Dementia
    3. Alzheimers Disease
    4. Vascular Dementia
    5. Other Indications
  2. U.S. Dementia Drugs Market, By Drug Class
    1. MAO-B Inhibitors
    2. Glutamate Inhibitors
    3. Cholinesterase Inhibitors
4. Canada
Europe
1. Europe Dementia Drugs Market, By Indications
  1. Lewy Body Dementia
  2. Parkinsons Disease Dementia
  3. Alzheimers Disease
  4. Vascular Dementia
  5. Other Indications
2. Europe Dementia Drugs Market, By Drug Class
  1. MAO-B Inhibitors
  2. Glutamate Inhibitors
  3. Cholinesterase Inhibitors
3. U.K.
  1. U.K. Dementia Drugs Market, By Indications
    1. Lewy Body Dementia
    2. Parkinsons Disease Dementia
    3. Alzheimers Disease
    4. Vascular Dementia
    5. Other Indications
  2. U.K. Dementia Drugs Market, By Drug Class
    1. MAO-B Inhibitors
    2. Glutamate Inhibitors
    3. Cholinesterase Inhibitors
4. Germany
5. France
6. Spain
7. Italy
8. Russia
9. Nordic
10. Benelux
11. Rest of Europe
APAC
1. APAC Dementia Drugs Market, By Indications
  1. Lewy Body Dementia
  2. Parkinsons Disease Dementia
  3. Alzheimers Disease
  4. Vascular Dementia
  5. Other Indications
2. APAC Dementia Drugs Market, By Drug Class
  1. MAO-B Inhibitors
  2. Glutamate Inhibitors
  3. Cholinesterase Inhibitors
3. China
  1. China Dementia Drugs Market, By Indications
    1. Lewy Body Dementia
    2. Parkinsons Disease Dementia
    3. Alzheimers Disease
    4. Vascular Dementia
    5. Other Indications
  2. China Dementia Drugs Market, By Drug Class
    1. MAO-B Inhibitors
    2. Glutamate Inhibitors
    3. Cholinesterase Inhibitors
4. Korea
5. Japan
6. India
7. Australia
8. Taiwan
9. South East Asia
10. Rest of Asia-Pacific
Middle East and Africa
1. Middle East and Africa Dementia Drugs Market, By Indications
  1. Lewy Body Dementia
  2. Parkinsons Disease Dementia
  3. Alzheimers Disease
  4. Vascular Dementia
  5. Other Indications
2. Middle East and Africa Dementia Drugs Market, By Drug Class
  1. MAO-B Inhibitors
  2. Glutamate Inhibitors
  3. Cholinesterase Inhibitors
3. UAE
  1. UAE Dementia Drugs Market, By Indications
    1. Lewy Body Dementia
    2. Parkinsons Disease Dementia
    3. Alzheimers Disease
    4. Vascular Dementia
    5. Other Indications
  2. UAE Dementia Drugs Market, By Drug Class
    1. MAO-B Inhibitors
    2. Glutamate Inhibitors
    3. Cholinesterase Inhibitors
4. Turkey
5. Saudi Arabia
6. South Africa
7. Egypt
8. Nigeria
9. Rest of MEA
LATAM
1. LATAM Dementia Drugs Market, By Indications
  1. Lewy Body Dementia
  2. Parkinsons Disease Dementia
  3. Alzheimers Disease
  4. Vascular Dementia
  5. Other Indications
2. LATAM Dementia Drugs Market, By Drug Class
  1. MAO-B Inhibitors
  2. Glutamate Inhibitors
  3. Cholinesterase Inhibitors
3. Brazil
  1. Brazil Dementia Drugs Market, By Indications
    1. Lewy Body Dementia
    2. Parkinsons Disease Dementia
    3. Alzheimers Disease
    4. Vascular Dementia
    5. Other Indications
  2. Brazil Dementia Drugs Market, By Drug Class
    1. MAO-B Inhibitors
    2. Glutamate Inhibitors
    3. Cholinesterase Inhibitors
4. Mexico
5. Argentina
6. Chile
7. Colombia
8. Rest of LATAM